0 |
BLOOD PRESSURE AMBULATORY ABNORMAL |
7 |
0.4667 |
1 |
HYPER IGE SYNDROME |
43 |
0.4526 |
2 |
OCCUPATIONAL ASTHMA |
20 |
0.4000 |
3 |
CONGENITAL HIATUS HERNIA |
25 |
0.3846 |
4 |
TOTAL LUNG CAPACITY INCREASED |
55 |
0.3481 |
5 |
DYSPONESIS |
3 |
0.2308 |
6 |
FUNGAL DISEASE CARRIER |
14 |
0.2090 |
7 |
AIRWAY REMODELLING |
16 |
0.1905 |
8 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
58 |
0.1859 |
9 |
URINARY TRACT DISCOMFORT |
51 |
0.1700 |
10 |
NEUROSENSORY HYPOACUSIS |
14 |
0.1474 |
11 |
LUNG DIFFUSION DISORDER |
14 |
0.1414 |
12 |
ALVEOLAR OSTEITIS |
50 |
0.1397 |
13 |
MYCOBACTERIUM TEST POSITIVE |
19 |
0.1195 |
14 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
52 |
0.0904 |
15 |
BILEVEL POSITIVE AIRWAY PRESSURE |
8 |
0.0879 |
16 |
INTENTIONAL DEVICE MISUSE |
336 |
0.0826 |
17 |
LUNG DIFFUSION TEST DECREASED |
19 |
0.0809 |
18 |
NSAID EXACERBATED RESPIRATORY DISEASE |
4 |
0.0667 |
19 |
ANIMAL SCRATCH |
49 |
0.0644 |
20 |
VITAL CAPACITY DECREASED |
23 |
0.0625 |
21 |
OESOPHAGEAL DILATATION |
20 |
0.0568 |
22 |
MEDIASTINAL SHIFT |
3 |
0.0556 |
23 |
RESTRICTIVE PULMONARY DISEASE |
51 |
0.0555 |
24 |
NASAL POLYPS |
117 |
0.0537 |
25 |
PRESBYACUSIS |
14 |
0.0502 |
26 |
FEMALE STERILISATION |
19 |
0.0463 |
27 |
SINUS PAIN |
73 |
0.0452 |
28 |
INGUINAL HERNIA REPAIR |
13 |
0.0433 |
29 |
BREAST CONSERVING SURGERY |
15 |
0.0425 |
30 |
BRONCHIECTASIS |
193 |
0.0403 |
31 |
POSITIVE AIRWAY PRESSURE THERAPY |
3 |
0.0385 |
32 |
PANCREATIC CALCIFICATION |
4 |
0.0360 |
33 |
CARCINOMA IN SITU |
5 |
0.0352 |
34 |
OBSTRUCTIVE AIRWAYS DISORDER |
313 |
0.0350 |
35 |
TUNNEL VISION |
51 |
0.0347 |
36 |
POLYCYSTIC OVARIES |
45 |
0.0319 |
37 |
PNEUMOTHORAX SPONTANEOUS |
16 |
0.0307 |
38 |
POLYMYALGIA RHEUMATICA |
65 |
0.0301 |
39 |
ANTI-THYROID ANTIBODY |
2 |
0.0294 |
40 |
RESPIRATORY TRACT OEDEMA |
16 |
0.0294 |
41 |
BLOOD IMMUNOGLOBULIN E DECREASED |
3 |
0.0291 |
42 |
CAROTID ARTERIOSCLEROSIS |
21 |
0.0275 |
43 |
LIPOHYPERTROPHY |
14 |
0.0275 |
44 |
DEVICE MALFUNCTION |
1275 |
0.0274 |
45 |
DEVICE FAILURE |
296 |
0.0260 |
46 |
ATOPY |
5 |
0.0259 |
47 |
BRONCHIAL WALL THICKENING |
14 |
0.0246 |
48 |
EAR CONGESTION |
51 |
0.0241 |
49 |
BREATH SOUNDS ABNORMAL |
88 |
0.0239 |
50 |
STRESS URINARY INCONTINENCE |
22 |
0.0236 |
51 |
INSPIRATORY CAPACITY DECREASED |
3 |
0.0229 |
52 |
BLADDER PAIN |
57 |
0.0228 |
53 |
MALIGNANT MELANOMA IN SITU |
25 |
0.0225 |
54 |
BRONCHITIS CHRONIC |
43 |
0.0203 |
55 |
OROPHARYNGEAL CANDIDIASIS |
14 |
0.0197 |
56 |
PARANASAL SINUS DISCOMFORT |
52 |
0.0196 |
57 |
MITRAL VALVE REPAIR |
5 |
0.0186 |
58 |
WOUND COMPLICATION |
51 |
0.0184 |
59 |
LAPAROSCOPIC SURGERY |
3 |
0.0182 |
60 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
124 |
0.0177 |
61 |
EOSINOPHILIC BRONCHITIS |
3 |
0.0175 |
62 |
RHINITIS ALLERGIC |
57 |
0.0169 |
63 |
BRONCHIAL OBSTRUCTION |
20 |
0.0167 |
64 |
VOCAL CORD INFLAMMATION |
4 |
0.0167 |
65 |
FULL BLOOD COUNT ABNORMAL |
107 |
0.0166 |
66 |
OBSTRUCTIVE PANCREATITIS |
6 |
0.0164 |
67 |
BREAST NEOPLASM |
14 |
0.0162 |
68 |
SPUTUM PURULENT |
9 |
0.0160 |
69 |
CHRONIC SINUSITIS |
44 |
0.0159 |
70 |
LUNG OPACITY |
20 |
0.0158 |
71 |
GRANULOMATOSIS WITH POLYANGIITIS |
13 |
0.0157 |
72 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT |
7 |
0.0155 |
73 |
BODY HEIGHT DECREASED |
148 |
0.0152 |
74 |
TOTAL LUNG CAPACITY DECREASED |
18 |
0.0151 |
75 |
WOUND SECRETION |
51 |
0.0151 |
76 |
ORTHOSTATIC INTOLERANCE |
9 |
0.0151 |
77 |
SPUTUM DISCOLOURED |
110 |
0.0151 |
78 |
ALLERGY TO ANIMAL |
10 |
0.0150 |
79 |
STENOTROPHOMONAS INFECTION |
14 |
0.0148 |
80 |
SARCOIDOSIS |
55 |
0.0147 |
81 |
NEPHRECTOMY |
17 |
0.0146 |
82 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
605 |
0.0143 |
83 |
MACROCYTOSIS |
14 |
0.0143 |
84 |
JAUNDICE CHOLESTATIC |
42 |
0.0142 |
85 |
MUSCLE STRENGTH ABNORMAL |
3 |
0.0141 |
86 |
MYOPATHY |
97 |
0.0139 |
87 |
KYPHOSIS |
21 |
0.0138 |
88 |
CALCULUS URINARY |
17 |
0.0135 |
89 |
PERSONAL RELATIONSHIP ISSUE |
8 |
0.0135 |
90 |
LORDOSIS |
4 |
0.0134 |
91 |
HYPOMANIA |
41 |
0.0132 |
92 |
SINUSITIS BACTERIAL |
9 |
0.0131 |
93 |
HYPERCAPNIA |
30 |
0.0127 |
94 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
11 |
0.0125 |
95 |
DEVICE DEFECTIVE |
66 |
0.0122 |
96 |
CREPITATIONS |
32 |
0.0121 |
97 |
RALES |
57 |
0.0119 |
98 |
NOCTURNAL DYSPNOEA |
12 |
0.0119 |
99 |
EMPHYSEMA |
101 |
0.0119 |
100 |
DYSLIPIDAEMIA |
47 |
0.0118 |
101 |
BODY HEIGHT INCREASED |
3 |
0.0118 |
102 |
ANGIOPLASTY |
15 |
0.0115 |
103 |
BLOOD IRON DECREASED |
96 |
0.0113 |
104 |
SALIVA DISCOLOURATION |
3 |
0.0110 |
105 |
INTENTIONAL PRODUCT MISUSE |
740 |
0.0108 |
106 |
FORCED EXPIRATORY VOLUME DECREASED |
23 |
0.0107 |
107 |
PULMONARY FUNCTION TEST DECREASED |
39 |
0.0106 |
108 |
PAINFUL RESPIRATION |
21 |
0.0100 |
109 |
WHEEZING |
432 |
0.0100 |
110 |
INTENTIONAL DEVICE USE ISSUE |
4 |
0.0100 |
111 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
5 |
0.0097 |
112 |
REVERSIBLE AIRWAYS OBSTRUCTION |
4 |
0.0092 |
113 |
VITAMIN D INCREASED |
4 |
0.0089 |
114 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
185 |
0.0089 |
115 |
LUNG CONSOLIDATION |
20 |
0.0088 |
116 |
PULMONARY FUNCTION TEST ABNORMAL |
11 |
0.0088 |
117 |
MITE ALLERGY |
3 |
0.0087 |
118 |
GLOSSITIS |
24 |
0.0082 |
119 |
LUNG HYPERINFLATION |
6 |
0.0082 |
120 |
DEVICE ISSUE |
475 |
0.0080 |
121 |
NASAL DISCHARGE DISCOLOURATION |
8 |
0.0079 |
122 |
ASTHMA |
611 |
0.0078 |
123 |
AMNESTIC DISORDER |
3 |
0.0078 |
124 |
PRODUCT TASTE ABNORMAL |
82 |
0.0078 |
125 |
ASTHMA EXERCISE INDUCED |
2 |
0.0077 |
126 |
PRODUCTIVE COUGH |
265 |
0.0076 |
127 |
OXYGEN CONSUMPTION DECREASED |
4 |
0.0076 |
128 |
BRONCHIOLITIS |
21 |
0.0075 |
129 |
PULMONARY PAIN |
15 |
0.0075 |
130 |
FRUSTRATION TOLERANCE DECREASED |
44 |
0.0075 |
131 |
CARDIAC MURMUR |
56 |
0.0074 |
132 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
6 |
0.0073 |
133 |
GRANULOMA |
20 |
0.0072 |
134 |
AORTIC ARTERIOSCLEROSIS |
15 |
0.0072 |
135 |
SKIN LACERATION |
53 |
0.0070 |
136 |
MESOTHELIOMA |
3 |
0.0070 |
137 |
SINUS DISORDER |
110 |
0.0070 |
138 |
ADENOCARCINOMA |
13 |
0.0070 |
139 |
LUNG NEOPLASM |
26 |
0.0068 |
140 |
OBSTRUCTION |
19 |
0.0068 |
141 |
CREATININE RENAL CLEARANCE INCREASED |
4 |
0.0067 |
142 |
CUSHINGOID |
16 |
0.0066 |
143 |
BLOOD IMMUNOGLOBULIN E INCREASED |
12 |
0.0064 |
144 |
HYPERCHOLESTEROLAEMIA |
41 |
0.0063 |
145 |
BENIGN PROSTATIC HYPERPLASIA |
27 |
0.0062 |
146 |
DRUG DOSE OMISSION |
1017 |
0.0061 |
147 |
BODY MASS INDEX INCREASED |
6 |
0.0061 |
148 |
UPPER-AIRWAY COUGH SYNDROME |
36 |
0.0059 |
149 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
186 |
0.0059 |
150 |
DIZZINESS EXERTIONAL |
3 |
0.0059 |
151 |
BLOOD TEST ABNORMAL |
61 |
0.0058 |
152 |
BODY TEMPERATURE INCREASED |
99 |
0.0058 |
153 |
PULMONARY MASS |
65 |
0.0057 |
154 |
LOWER RESPIRATORY TRACT INFECTION |
181 |
0.0056 |
155 |
ANION GAP INCREASED |
6 |
0.0055 |
156 |
EOSINOPHIL COUNT INCREASED |
35 |
0.0055 |
157 |
RESPIRATORY SYMPTOM |
9 |
0.0055 |
158 |
DYSPNOEA EXERTIONAL |
153 |
0.0054 |
159 |
BLOOD CHOLESTEROL |
2 |
0.0054 |
160 |
BRONCHITIS BACTERIAL |
3 |
0.0053 |
161 |
OXYGEN THERAPY |
5 |
0.0053 |
162 |
SLEEP APNOEA SYNDROME |
85 |
0.0053 |
163 |
HALO VISION |
5 |
0.0052 |
164 |
THROAT LESION |
3 |
0.0051 |
165 |
JOINT INJURY |
85 |
0.0050 |
166 |
RESPIRATORY TRACT IRRITATION |
4 |
0.0050 |
167 |
PRODUCT QUALITY ISSUE |
592 |
0.0049 |
168 |
SMALL CELL LUNG CANCER |
5 |
0.0049 |
169 |
ACCIDENT AT HOME |
2 |
0.0049 |
170 |
PRODUCT OUTER PACKAGING ISSUE |
3 |
0.0049 |
171 |
NEUROPSYCHIATRIC SYMPTOMS |
5 |
0.0049 |
172 |
ORAL CANDIDIASIS |
47 |
0.0048 |
173 |
SPUTUM INCREASED |
7 |
0.0047 |
174 |
PULMONARY CONGESTION |
48 |
0.0046 |
175 |
SCHIZOPHRENIA |
42 |
0.0046 |
176 |
REFLUX GASTRITIS |
4 |
0.0045 |
177 |
VENTRICULAR HYPOKINESIA |
12 |
0.0045 |
178 |
HYPOKINESIA |
54 |
0.0045 |
179 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
208 |
0.0045 |
180 |
PAROTITIS |
4 |
0.0044 |
181 |
HYPOAESTHESIA ORAL |
53 |
0.0043 |
182 |
SENSITIVITY TO WEATHER CHANGE |
16 |
0.0043 |
183 |
LUNG DISORDER |
161 |
0.0043 |
184 |
LIMB DEFORMITY |
6 |
0.0043 |
185 |
OSTEOPOROTIC FRACTURE |
6 |
0.0042 |
186 |
GLAUCOMA |
65 |
0.0042 |
187 |
BLOOD CHOLESTEROL ABNORMAL |
15 |
0.0041 |
188 |
BLOOD PRESSURE SYSTOLIC INCREASED |
63 |
0.0041 |
189 |
TONGUE INJURY |
3 |
0.0040 |
190 |
BLOOD COUNT ABNORMAL |
62 |
0.0040 |
191 |
INFUSION SITE BRUISING |
5 |
0.0040 |
192 |
MACULAR DEGENERATION |
36 |
0.0039 |
193 |
LIMB INJURY |
79 |
0.0038 |
194 |
BLOOD URINE PRESENT |
61 |
0.0038 |
195 |
PNEUMONIA INFLUENZAL |
3 |
0.0038 |
196 |
DEVICE USE ISSUE |
37 |
0.0038 |
197 |
DRUG DELIVERY SYSTEM ISSUE |
4 |
0.0038 |
198 |
MULTIPLE ALLERGIES |
22 |
0.0038 |
199 |
RENAL CYST |
25 |
0.0037 |
200 |
DEVICE DAMAGE |
3 |
0.0037 |
201 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
100 |
0.0037 |
202 |
PERICARDIAL HAEMORRHAGE |
7 |
0.0037 |
203 |
VOCAL CORD DISORDER |
6 |
0.0037 |
204 |
PERIPHERAL VASCULAR DISORDER |
17 |
0.0037 |
205 |
PSEUDOMONAS INFECTION |
23 |
0.0036 |
206 |
EAR PAIN |
56 |
0.0036 |
207 |
GASTROENTERITIS |
42 |
0.0036 |
208 |
OXYGEN SATURATION ABNORMAL |
7 |
0.0036 |
209 |
CORONARY ARTERY DISEASE |
100 |
0.0036 |
210 |
ABSCESS |
45 |
0.0036 |
211 |
DYSPNOEA |
1615 |
0.0036 |
212 |
INSURANCE ISSUE |
20 |
0.0036 |
213 |
HYPOACUSIS |
113 |
0.0036 |
214 |
SUFFOCATION FEELING |
7 |
0.0035 |
215 |
URINE FLOW DECREASED |
7 |
0.0035 |
216 |
FANCONI SYNDROME |
4 |
0.0035 |
217 |
RESTLESS LEGS SYNDROME |
52 |
0.0035 |
218 |
SECRETION DISCHARGE |
30 |
0.0034 |
219 |
CHRONIC RESPIRATORY FAILURE |
3 |
0.0034 |
220 |
GASTROOESOPHAGEAL REFLUX DISEASE |
213 |
0.0034 |
221 |
BRONCHITIS |
207 |
0.0033 |
222 |
TYPE 2 DIABETES MELLITUS |
89 |
0.0033 |
223 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I |
3 |
0.0033 |
224 |
SYMPTOM RECURRENCE |
9 |
0.0033 |
225 |
RESPIRATION ABNORMAL |
16 |
0.0032 |
226 |
DYSPHONIA |
147 |
0.0032 |
227 |
ASPIRIN-EXACERBATED RESPIRATORY DISEASE |
2 |
0.0032 |
228 |
PRODUCT DOSE OMISSION |
210 |
0.0032 |
229 |
LUNG NEOPLASM MALIGNANT |
109 |
0.0030 |
230 |
APHONIA |
32 |
0.0030 |
231 |
MICTURITION URGENCY |
27 |
0.0030 |
232 |
BRONCHIAL DISORDER |
4 |
0.0030 |
233 |
SKIN LESION |
63 |
0.0030 |
234 |
CHOKING |
45 |
0.0030 |
235 |
CONJUNCTIVITIS ALLERGIC |
3 |
0.0030 |
236 |
CATARACT |
130 |
0.0029 |
237 |
DISABILITY |
45 |
0.0029 |
238 |
TUMOUR PAIN |
3 |
0.0029 |
239 |
PROSTATITIS |
7 |
0.0028 |
240 |
CANDIDA INFECTION |
34 |
0.0028 |
241 |
SUBCUTANEOUS HAEMATOMA |
3 |
0.0027 |
242 |
RIB FRACTURE |
44 |
0.0027 |
243 |
PYELONEPHRITIS |
18 |
0.0027 |
244 |
NOSOCOMIAL INFECTION |
5 |
0.0026 |
245 |
OROPHARYNGEAL DISCOMFORT |
15 |
0.0026 |
246 |
NASAL SEPTUM DEVIATION |
4 |
0.0026 |
247 |
OVERWEIGHT |
11 |
0.0026 |
248 |
COUGH |
551 |
0.0026 |
249 |
OESOPHAGEAL SPASM |
4 |
0.0026 |
250 |
DYSURIA |
78 |
0.0026 |
251 |
LUMBAR VERTEBRAL FRACTURE |
9 |
0.0026 |
252 |
VISUAL ACUITY REDUCED |
78 |
0.0025 |
253 |
ECZEMA |
58 |
0.0025 |
254 |
HYPOTHYROIDISM |
60 |
0.0025 |
255 |
PROCEDURAL PAIN |
52 |
0.0025 |
256 |
WRIST FRACTURE |
24 |
0.0025 |
257 |
NEUROLOGICAL SYMPTOM |
11 |
0.0025 |
258 |
DERMATITIS ATOPIC |
34 |
0.0025 |
259 |
HEPATOTOXICITY |
41 |
0.0024 |
260 |
RHINITIS |
15 |
0.0024 |
261 |
MIDDLE INSOMNIA |
34 |
0.0024 |
262 |
CHEST DISCOMFORT |
189 |
0.0024 |
263 |
EOSINOPHILIA |
32 |
0.0024 |
264 |
INCREASED BRONCHIAL SECRETION |
4 |
0.0024 |
265 |
RESPIRATORY TRACT CONGESTION |
29 |
0.0024 |
266 |
CELLULITIS |
98 |
0.0024 |
267 |
DRY THROAT |
19 |
0.0023 |
268 |
BLOOD PRESSURE ABNORMAL |
34 |
0.0023 |
269 |
TYMPANIC MEMBRANE PERFORATION |
3 |
0.0023 |
270 |
PANIC ATTACK |
68 |
0.0023 |
271 |
GASTRITIS HAEMORRHAGIC |
3 |
0.0023 |
272 |
FEELING COLD |
52 |
0.0023 |
273 |
ESCHERICHIA INFECTION |
14 |
0.0023 |
274 |
PNEUMONIA |
568 |
0.0023 |
275 |
NASAL OEDEMA |
3 |
0.0023 |
276 |
TONGUE DISCOMFORT |
7 |
0.0023 |
277 |
ARTERIOSCLEROSIS CORONARY ARTERY |
12 |
0.0022 |
278 |
ARTERIAL HAEMORRHAGE |
2 |
0.0022 |
279 |
HEART RATE INCREASED |
174 |
0.0022 |
280 |
ABDOMINAL TENDERNESS |
9 |
0.0022 |
281 |
CORONARY ARTERY BYPASS |
11 |
0.0022 |
282 |
PANIC DISORDER |
7 |
0.0021 |
283 |
MYCOBACTERIAL INFECTION |
3 |
0.0021 |
284 |
READING DISORDER |
4 |
0.0021 |
285 |
MOVEMENT DISORDER |
56 |
0.0021 |
286 |
PNEUMONIA VIRAL |
5 |
0.0021 |
287 |
ARRHYTHMIA SUPRAVENTRICULAR |
2 |
0.0021 |
288 |
MITRAL VALVE PROLAPSE |
3 |
0.0021 |
289 |
NASAL CONGESTION |
90 |
0.0021 |
290 |
RESPIRATORY DISORDER |
49 |
0.0020 |
291 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
27 |
0.0020 |
292 |
POLLAKIURIA |
68 |
0.0020 |
293 |
TRANSIENT ISCHAEMIC ATTACK |
58 |
0.0020 |
294 |
HAEMATURIA |
59 |
0.0020 |
295 |
ORGANISING PNEUMONIA |
7 |
0.0020 |
296 |
VOCAL CORD PARALYSIS |
3 |
0.0020 |
297 |
UNDERWEIGHT |
3 |
0.0020 |
298 |
ANIMAL BITE |
4 |
0.0020 |
299 |
FANCONI SYNDROME ACQUIRED |
3 |
0.0020 |
300 |
OSTEOPOROSIS |
67 |
0.0020 |
301 |
BLOOD BILIRUBIN INCREASED |
44 |
0.0019 |
302 |
INTERVERTEBRAL DISC DISORDER |
7 |
0.0019 |
303 |
POLYP |
10 |
0.0019 |
304 |
CHEST INJURY |
3 |
0.0019 |
305 |
SINUSITIS |
153 |
0.0019 |
306 |
EYE DISORDER |
48 |
0.0019 |
307 |
RESPIRATORY TRACT INFECTION |
35 |
0.0018 |
308 |
NEPHROLITHIASIS |
63 |
0.0018 |
309 |
IDIOPATHIC PULMONARY FIBROSIS |
5 |
0.0018 |
310 |
VISUAL IMPAIRMENT |
166 |
0.0018 |
311 |
OXYGEN SATURATION DECREASED |
73 |
0.0018 |
312 |
CHOLELITHIASIS |
47 |
0.0017 |
313 |
DYSARTHRIA |
54 |
0.0017 |
314 |
PERIPHERAL VENOUS DISEASE |
3 |
0.0017 |
315 |
URINARY RETENTION |
46 |
0.0017 |
316 |
MEMORY IMPAIRMENT |
193 |
0.0017 |
317 |
WEIGHT GAIN POOR |
3 |
0.0017 |
318 |
PSYCHOTIC DISORDER |
42 |
0.0017 |
319 |
HYPERPARATHYROIDISM SECONDARY |
4 |
0.0017 |
320 |
DRUG DELIVERY SYSTEM MALFUNCTION |
6 |
0.0017 |
321 |
ENDOMETRIAL CANCER |
3 |
0.0017 |
322 |
LARYNGITIS |
14 |
0.0017 |
323 |
OXYGEN CONSUMPTION INCREASED |
3 |
0.0017 |
324 |
PANIC REACTION |
10 |
0.0017 |
325 |
OROPHARYNGEAL PAIN |
121 |
0.0017 |
326 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
6 |
0.0016 |
327 |
CARDIAC FAILURE |
105 |
0.0016 |
328 |
HERNIA |
24 |
0.0016 |
329 |
PRODUCT LABEL ISSUE |
8 |
0.0016 |
330 |
DEVICE DELIVERY SYSTEM ISSUE |
13 |
0.0016 |
331 |
EAR DISORDER |
6 |
0.0016 |
332 |
CATHETER SITE PAIN |
3 |
0.0016 |
333 |
BRONCHOSPASM |
19 |
0.0016 |
334 |
INFLUENZA |
130 |
0.0016 |
335 |
AGE-RELATED MACULAR DEGENERATION |
2 |
0.0016 |
336 |
GLUCOSE TOLERANCE IMPAIRED |
7 |
0.0015 |
337 |
PRODUCT RESIDUE PRESENT |
5 |
0.0015 |
338 |
OESOPHAGEAL DISORDER |
5 |
0.0015 |
339 |
HYPOPNOEA |
4 |
0.0015 |
340 |
HYPERTHYROIDISM |
17 |
0.0015 |
341 |
MUSCULOSKELETAL DISCOMFORT |
21 |
0.0015 |
342 |
LUNG INFECTION |
24 |
0.0015 |
343 |
HYPOGAMMAGLOBULINAEMIA |
6 |
0.0015 |
344 |
SKIN INJURY |
4 |
0.0015 |
345 |
WOUND |
30 |
0.0015 |
346 |
REGURGITATION |
4 |
0.0015 |
347 |
INCREASED UPPER AIRWAY SECRETION |
7 |
0.0015 |
348 |
CONCUSSION |
9 |
0.0015 |
349 |
NEUTROPENIC SEPSIS |
9 |
0.0015 |
350 |
PSYCHIATRIC SYMPTOM |
9 |
0.0015 |
351 |
BREATH ODOUR |
3 |
0.0015 |
352 |
DRUG DOSE OMISSION BY DEVICE |
26 |
0.0015 |
353 |
SPINAL COLUMN STENOSIS |
7 |
0.0015 |
354 |
IMMUNE SYSTEM DISORDER |
15 |
0.0015 |
355 |
DYSGEUSIA |
93 |
0.0015 |
356 |
BLISTER |
63 |
0.0015 |
357 |
SINUS TACHYCARDIA |
17 |
0.0015 |
358 |
HIATUS HERNIA |
16 |
0.0015 |
359 |
PRODUCT PACKAGING ISSUE |
10 |
0.0015 |
360 |
BASAL CELL CARCINOMA |
18 |
0.0015 |
361 |
EXTRA DOSE ADMINISTERED |
32 |
0.0014 |
362 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0014 |
363 |
HICCUPS |
9 |
0.0014 |
364 |
RESPIRATORY RATE INCREASED |
10 |
0.0014 |
365 |
COMPRESSION FRACTURE |
5 |
0.0014 |
366 |
ATYPICAL PNEUMONIA |
3 |
0.0014 |
367 |
HAEMOPTYSIS |
32 |
0.0014 |
368 |
AORTIC ANEURYSM |
9 |
0.0014 |
369 |
ADRENAL DISORDER |
2 |
0.0014 |
370 |
NASAL DISORDER |
3 |
0.0014 |
371 |
DECREASED ACTIVITY |
11 |
0.0014 |
372 |
PLEURISY |
7 |
0.0014 |
373 |
TUMOUR HAEMORRHAGE |
3 |
0.0014 |
374 |
AORTIC VALVE STENOSIS |
2 |
0.0014 |
375 |
RHINORRHOEA |
66 |
0.0014 |
376 |
CHILLS |
128 |
0.0013 |
377 |
OEDEMA |
57 |
0.0013 |
378 |
DYSPNOEA AT REST |
3 |
0.0013 |
379 |
PRODUCT DOSE OMISSION ISSUE |
177 |
0.0013 |
380 |
ATRIAL FIBRILLATION |
105 |
0.0013 |
381 |
UNDERDOSE |
77 |
0.0013 |
382 |
PRODUCT USE ISSUE |
186 |
0.0013 |
383 |
HEAD INJURY |
33 |
0.0013 |
384 |
ORAL DISCOMFORT |
15 |
0.0013 |
385 |
ACUTE RESPIRATORY FAILURE |
19 |
0.0013 |
386 |
CAROTID ARTERY STENOSIS |
4 |
0.0013 |
387 |
BODY TEMPERATURE DECREASED |
11 |
0.0013 |
388 |
PRODUCT USE IN UNAPPROVED INDICATION |
203 |
0.0013 |
389 |
TEMPERATURE INTOLERANCE |
10 |
0.0013 |
390 |
QUALITY OF LIFE DECREASED |
14 |
0.0013 |
391 |
IMPAIRED QUALITY OF LIFE |
12 |
0.0013 |
392 |
HYPERTENSION |
217 |
0.0013 |
393 |
CLAVICLE FRACTURE |
4 |
0.0013 |
394 |
VITAMIN D DECREASED |
9 |
0.0013 |
395 |
HEART VALVE INCOMPETENCE |
3 |
0.0013 |
396 |
OBESITY |
15 |
0.0013 |
397 |
THROAT CLEARING |
3 |
0.0013 |
398 |
MUSCULAR WEAKNESS |
113 |
0.0012 |
399 |
BLOOD PRESSURE INCREASED |
152 |
0.0012 |
400 |
ENDOCARDITIS |
5 |
0.0012 |
401 |
HAEMOGLOBIN DECREASED |
103 |
0.0012 |
402 |
RENAL TUBULAR DISORDER |
3 |
0.0012 |
403 |
HYPERVENTILATION |
6 |
0.0012 |
404 |
HEAD DISCOMFORT |
16 |
0.0012 |
405 |
SPINAL STENOSIS |
3 |
0.0012 |
406 |
ACCIDENT |
11 |
0.0012 |
407 |
ATAXIA |
12 |
0.0012 |
408 |
SNEEZING |
20 |
0.0012 |
409 |
PERIPHERAL SWELLING |
138 |
0.0012 |
410 |
DRUG SCREEN FALSE POSITIVE |
3 |
0.0012 |
411 |
DEMENTIA |
24 |
0.0012 |
412 |
VITAMIN D DEFICIENCY |
9 |
0.0012 |
413 |
NERVOUSNESS |
53 |
0.0012 |
414 |
SPONDYLITIS |
3 |
0.0012 |
415 |
URINARY TRACT DISORDER |
4 |
0.0011 |
416 |
FOOT DEFORMITY |
10 |
0.0011 |
417 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
4 |
0.0011 |
418 |
BLOOD URIC ACID INCREASED |
5 |
0.0011 |
419 |
CONDITION AGGRAVATED |
247 |
0.0011 |
420 |
EAR DISCOMFORT |
9 |
0.0011 |
421 |
MUSCULOSKELETAL CHEST PAIN |
14 |
0.0011 |
422 |
THERAPEUTIC RESPONSE CHANGED |
3 |
0.0011 |
423 |
WHEELCHAIR USER |
4 |
0.0011 |
424 |
EXERCISE TOLERANCE DECREASED |
5 |
0.0011 |
425 |
THYROID MASS |
3 |
0.0011 |
426 |
ABNORMAL LOSS OF WEIGHT |
6 |
0.0011 |
427 |
GAIT DISTURBANCE |
173 |
0.0011 |
428 |
PRODUCT PACKAGING QUANTITY ISSUE |
7 |
0.0011 |
429 |
THROAT IRRITATION |
38 |
0.0011 |
430 |
WEIGHT DECREASED |
244 |
0.0011 |
431 |
PULMONARY HYPERTENSION |
19 |
0.0011 |
432 |
DRY MOUTH |
69 |
0.0011 |
433 |
INFLUENZA LIKE ILLNESS |
76 |
0.0011 |
434 |
ANXIETY DISORDER |
3 |
0.0011 |
435 |
ASPIRATION |
9 |
0.0011 |
436 |
MELAENA |
20 |
0.0011 |
437 |
THYROID DISORDER |
13 |
0.0011 |
438 |
BURNING SENSATION |
62 |
0.0011 |
439 |
HEPATIC ENZYME INCREASED |
55 |
0.0011 |
440 |
SUSPECTED COVID-19 |
3 |
0.0011 |
441 |
AUTOIMMUNE THYROIDITIS |
3 |
0.0011 |
442 |
BACK DISORDER |
14 |
0.0011 |
443 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
25 |
0.0011 |
444 |
UPPER RESPIRATORY TRACT INFECTION |
38 |
0.0011 |
445 |
FLANK PAIN |
8 |
0.0011 |
446 |
WEIGHT FLUCTUATION |
8 |
0.0010 |
447 |
CARDIAC FAILURE CONGESTIVE |
77 |
0.0010 |
448 |
SEASONAL ALLERGY |
10 |
0.0010 |
449 |
NON-CARDIAC CHEST PAIN |
3 |
0.0010 |
450 |
BALANCE DISORDER |
74 |
0.0010 |
451 |
OFF LABEL USE |
577 |
0.0010 |
452 |
DIABETES MELLITUS |
66 |
0.0010 |
453 |
SYNCOPE |
84 |
0.0010 |
454 |
FOREIGN BODY |
4 |
0.0010 |
455 |
OEDEMA PERIPHERAL |
107 |
0.0010 |
456 |
NASAL DRYNESS |
5 |
0.0010 |
457 |
CHOLECYSTECTOMY |
9 |
0.0010 |
458 |
MUSCLE DISORDER |
7 |
0.0010 |
459 |
EXTRASYSTOLES |
6 |
0.0010 |
460 |
CORONARY ARTERY OCCLUSION |
12 |
0.0010 |
461 |
HIP FRACTURE |
25 |
0.0010 |
462 |
TASTE DISORDER |
11 |
0.0010 |
463 |
WEIGHT INCREASED |
172 |
0.0010 |
464 |
NODULE |
10 |
0.0010 |
465 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
3 |
0.0010 |
466 |
INABILITY TO AFFORD MEDICATION |
5 |
0.0010 |
467 |
BLADDER DISORDER |
8 |
0.0010 |
468 |
PNEUMOTHORAX |
12 |
0.0010 |
469 |
ORAL MUCOSAL BLISTERING |
5 |
0.0010 |
470 |
PULMONARY OEDEMA |
35 |
0.0010 |
471 |
INFLAMMATION |
36 |
0.0010 |
472 |
MIGRAINE |
69 |
0.0010 |
473 |
HEART RATE ABNORMAL |
4 |
0.0010 |
474 |
MALAISE |
346 |
0.0010 |
475 |
OEDEMA MOUTH |
3 |
0.0010 |
476 |
ANKLE FRACTURE |
12 |
0.0009 |
477 |
CARDIAC DISORDER |
74 |
0.0009 |
478 |
INTENTIONAL PRODUCT USE ISSUE |
59 |
0.0009 |
479 |
PROSTATOMEGALY |
3 |
0.0009 |
480 |
BLOOD CHOLESTEROL INCREASED |
34 |
0.0009 |
481 |
SINUS CONGESTION |
10 |
0.0009 |
482 |
EYE INFLAMMATION |
6 |
0.0009 |
483 |
NON-SMALL CELL LUNG CANCER |
3 |
0.0009 |
484 |
BREAST MASS |
5 |
0.0009 |
485 |
NEPHROGENIC ANAEMIA |
4 |
0.0009 |
486 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0009 |
487 |
SLEEP DISORDER |
47 |
0.0009 |
488 |
DYSPEPSIA |
70 |
0.0009 |
489 |
HAEMORRHAGIC ANAEMIA |
4 |
0.0009 |
490 |
CHOKING SENSATION |
4 |
0.0009 |
491 |
NASOPHARYNGITIS |
127 |
0.0009 |
492 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
5 |
0.0009 |
493 |
DIVERTICULUM |
6 |
0.0009 |
494 |
ARTERIAL OCCLUSIVE DISEASE |
6 |
0.0009 |
495 |
BACK INJURY |
7 |
0.0009 |
496 |
FOOT FRACTURE |
14 |
0.0009 |
497 |
ATRIAL FLUTTER |
6 |
0.0009 |
498 |
SKIN ABRASION |
3 |
0.0009 |
499 |
OCULAR DISCOMFORT |
6 |
0.0009 |
500 |
LUNG INFILTRATION |
7 |
0.0009 |
501 |
INCORRECT DOSE ADMINISTERED |
128 |
0.0009 |
502 |
CLOSTRIDIUM DIFFICILE INFECTION |
14 |
0.0009 |
503 |
PNEUMONITIS |
17 |
0.0009 |
504 |
ABDOMINAL DISTENSION |
70 |
0.0009 |
505 |
END STAGE RENAL DISEASE |
14 |
0.0008 |
506 |
SPINAL FRACTURE |
13 |
0.0008 |
507 |
IMMOBILE |
3 |
0.0008 |
508 |
VIRAL INFECTION |
21 |
0.0008 |
509 |
HYPOXIA |
23 |
0.0008 |
510 |
FACIAL BONES FRACTURE |
3 |
0.0008 |
511 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
12 |
0.0008 |
512 |
BONE CANCER |
3 |
0.0008 |
513 |
FALL |
224 |
0.0008 |
514 |
BEDRIDDEN |
9 |
0.0008 |
515 |
COVID-19 PNEUMONIA |
7 |
0.0008 |
516 |
STAPHYLOCOCCAL INFECTION |
23 |
0.0008 |
517 |
POOR PERIPHERAL CIRCULATION |
3 |
0.0008 |
518 |
CARDIAC VALVE DISEASE |
4 |
0.0008 |
519 |
HERPES ZOSTER |
38 |
0.0008 |
520 |
ARTHRITIS |
51 |
0.0008 |
521 |
GUILLAIN-BARRE SYNDROME |
3 |
0.0008 |
522 |
INCORRECT DOSAGE ADMINISTERED |
3 |
0.0008 |
523 |
CATHETERISATION CARDIAC |
3 |
0.0008 |
524 |
BLINDNESS |
25 |
0.0008 |
525 |
ILL-DEFINED DISORDER |
27 |
0.0008 |
526 |
ABDOMINAL HERNIA |
3 |
0.0008 |
527 |
DYSPHAGIA |
58 |
0.0008 |
528 |
SCOLIOSIS |
4 |
0.0008 |
529 |
SPINAL DISORDER |
6 |
0.0008 |
530 |
THROAT TIGHTNESS |
17 |
0.0008 |
531 |
SINUS HEADACHE |
4 |
0.0008 |
532 |
CHEST PAIN |
118 |
0.0008 |
533 |
MYOCARDIAL INFARCTION |
120 |
0.0008 |
534 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
6 |
0.0008 |
535 |
NASAL DISCOMFORT |
5 |
0.0008 |
536 |
HAEMORRHAGIC STROKE |
5 |
0.0008 |
537 |
JOINT RANGE OF MOTION DECREASED |
7 |
0.0008 |
538 |
NERVE INJURY |
7 |
0.0008 |
539 |
LIP DRY |
4 |
0.0007 |
540 |
RESPIRATORY DISTRESS |
17 |
0.0007 |
541 |
STENT PLACEMENT |
5 |
0.0007 |
542 |
STREPTOCOCCAL INFECTION |
3 |
0.0007 |
543 |
GASTROINTESTINAL INFECTION |
5 |
0.0007 |
544 |
ATELECTASIS |
6 |
0.0007 |
545 |
THERAPY CESSATION |
28 |
0.0007 |
546 |
HOSPICE CARE |
5 |
0.0007 |
547 |
FIBROMYALGIA |
13 |
0.0007 |
548 |
ILLNESS |
32 |
0.0007 |
549 |
PARAESTHESIA ORAL |
8 |
0.0007 |
550 |
ACUTE MYOCARDIAL INFARCTION |
18 |
0.0007 |
551 |
VISION BLURRED |
76 |
0.0007 |
552 |
TACHYCARDIA |
50 |
0.0007 |
553 |
WOUND INFECTION |
5 |
0.0007 |
554 |
PRODUCT USE COMPLAINT |
6 |
0.0007 |
555 |
SPEECH DISORDER |
30 |
0.0007 |
556 |
TENDERNESS |
6 |
0.0007 |
557 |
ECCHYMOSIS |
4 |
0.0007 |
558 |
FEELING ABNORMAL |
140 |
0.0007 |
559 |
PERICARDITIS |
7 |
0.0007 |
560 |
MOUTH ULCERATION |
11 |
0.0007 |
561 |
THINKING ABNORMAL |
11 |
0.0007 |
562 |
SPINAL COMPRESSION FRACTURE |
5 |
0.0007 |
563 |
BLOOD PRESSURE DIASTOLIC DECREASED |
4 |
0.0007 |
564 |
DRUG DEPENDENCE |
102 |
0.0007 |
565 |
MUSCLE SPASMS |
99 |
0.0007 |
566 |
OSTEOARTHRITIS |
22 |
0.0007 |
567 |
PRESCRIBED OVERDOSE |
10 |
0.0007 |
568 |
GALLBLADDER DISORDER |
10 |
0.0007 |
569 |
RETCHING |
11 |
0.0007 |
570 |
PELVIC FRACTURE |
4 |
0.0006 |
571 |
IRRITABILITY |
33 |
0.0006 |
572 |
DRY EYE |
20 |
0.0006 |
573 |
VISUAL FIELD DEFECT |
4 |
0.0006 |
574 |
INTESTINAL HAEMORRHAGE |
3 |
0.0006 |
575 |
BACK PAIN |
121 |
0.0006 |
576 |
UPPER LIMB FRACTURE |
11 |
0.0006 |
577 |
PYREXIA |
177 |
0.0006 |
578 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
92 |
0.0006 |
579 |
PNEUMONIA BACTERIAL |
4 |
0.0006 |
580 |
SALIVARY HYPERSECRETION |
5 |
0.0006 |
581 |
HAEMOGLOBIN ABNORMAL |
3 |
0.0006 |
582 |
DECREASED APPETITE |
112 |
0.0006 |
583 |
GOUT |
9 |
0.0006 |
584 |
BRAIN INJURY |
5 |
0.0006 |
585 |
DEVICE USE ERROR |
15 |
0.0006 |
586 |
ANGIOPATHY |
3 |
0.0006 |
587 |
NEPHROPATHY |
5 |
0.0006 |
588 |
URINARY TRACT INFECTION |
82 |
0.0006 |
589 |
LOCALISED INFECTION |
12 |
0.0006 |
590 |
PROSTATIC DISORDER |
3 |
0.0006 |
591 |
TREMOR |
85 |
0.0006 |
592 |
FEELING JITTERY |
10 |
0.0006 |
593 |
STRESS |
34 |
0.0006 |
594 |
EYE INFECTION |
5 |
0.0006 |
595 |
CARDIAC FAILURE ACUTE |
3 |
0.0006 |
596 |
LACRIMATION INCREASED |
13 |
0.0006 |
597 |
ORAL PAIN |
11 |
0.0006 |
598 |
OSTEONECROSIS OF JAW |
13 |
0.0006 |
599 |
HUNGER |
5 |
0.0006 |
600 |
MYALGIA |
81 |
0.0006 |
601 |
PULMONARY THROMBOSIS |
5 |
0.0006 |
602 |
POST-TRAUMATIC STRESS DISORDER |
3 |
0.0006 |
603 |
GASTROENTERITIS VIRAL |
8 |
0.0006 |
604 |
TENSION |
3 |
0.0006 |
605 |
SCRATCH |
4 |
0.0006 |
606 |
HYPERLIPIDAEMIA |
6 |
0.0006 |
607 |
PLEURAL EFFUSION |
29 |
0.0006 |
608 |
APHTHOUS ULCER |
3 |
0.0006 |
609 |
CARDIAC FLUTTER |
3 |
0.0006 |
610 |
DEPRESSION |
112 |
0.0006 |
611 |
INFUSION SITE ERYTHEMA |
3 |
0.0006 |
612 |
POLYNEUROPATHY |
5 |
0.0006 |
613 |
HEART RATE IRREGULAR |
11 |
0.0006 |
614 |
ANXIETY |
132 |
0.0006 |
615 |
ATRIOVENTRICULAR BLOCK COMPLETE |
3 |
0.0006 |
616 |
COLITIS ISCHAEMIC |
3 |
0.0006 |
617 |
APPARENT DEATH |
2 |
0.0006 |
618 |
TROPONIN INCREASED |
3 |
0.0006 |
619 |
MEDICATION ERROR |
25 |
0.0006 |
620 |
DIVERTICULITIS |
12 |
0.0005 |
621 |
ULCER HAEMORRHAGE |
3 |
0.0005 |
622 |
GROIN PAIN |
4 |
0.0005 |
623 |
DYSGRAPHIA |
3 |
0.0005 |
624 |
HYPERSENSITIVITY |
81 |
0.0005 |
625 |
AMNESIA |
30 |
0.0005 |
626 |
GENERAL PHYSICAL CONDITION ABNORMAL |
3 |
0.0005 |
627 |
CARDIOMEGALY |
6 |
0.0005 |
628 |
AGEUSIA |
11 |
0.0005 |
629 |
CEREBRAL DISORDER |
3 |
0.0005 |
630 |
HYPERTENSIVE CRISIS |
5 |
0.0005 |
631 |
BOWEL MOVEMENT IRREGULARITY |
3 |
0.0005 |
632 |
URINE OUTPUT DECREASED |
4 |
0.0005 |
633 |
SWOLLEN TONGUE |
14 |
0.0005 |
634 |
LARGE INTESTINE POLYP |
3 |
0.0005 |
635 |
SCIATICA |
6 |
0.0005 |
636 |
PAIN IN EXTREMITY |
130 |
0.0005 |
637 |
INTERNAL HAEMORRHAGE |
5 |
0.0005 |
638 |
LACERATION |
5 |
0.0005 |
639 |
SPINAL OPERATION |
4 |
0.0005 |
640 |
HAND FRACTURE |
3 |
0.0005 |
641 |
GASTROINTESTINAL HAEMORRHAGE |
39 |
0.0005 |
642 |
DRUG HYPERSENSITIVITY |
84 |
0.0005 |
643 |
DRUG DISPENSING ERROR |
8 |
0.0005 |
644 |
MOUTH HAEMORRHAGE |
3 |
0.0005 |
645 |
JOINT EFFUSION |
3 |
0.0005 |
646 |
KIDNEY INFECTION |
8 |
0.0005 |
647 |
MOBILITY DECREASED |
29 |
0.0005 |
648 |
TOXIC EPIDERMAL NECROLYSIS |
6 |
0.0005 |
649 |
ADRENAL INSUFFICIENCY |
4 |
0.0005 |
650 |
HYPOPHAGIA |
10 |
0.0005 |
651 |
POST PROCEDURAL HAEMORRHAGE |
5 |
0.0005 |
652 |
OVARIAN CANCER |
4 |
0.0005 |
653 |
TOOTH LOSS |
9 |
0.0005 |
654 |
BLOOD PRESSURE DECREASED |
27 |
0.0005 |
655 |
ANAL ABSCESS |
2 |
0.0005 |
656 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0005 |
657 |
GENERAL PHYSICAL HEALTH DETERIORATION |
42 |
0.0005 |
658 |
GASTRIC ULCER |
8 |
0.0005 |
659 |
PRODUCT CONTAINER ISSUE |
3 |
0.0005 |
660 |
HEARING IMPAIRED |
3 |
0.0005 |
661 |
PAROSMIA |
3 |
0.0005 |
662 |
ELECTROCARDIOGRAM QT PROLONGED |
14 |
0.0005 |
663 |
DEVICE DIFFICULT TO USE |
15 |
0.0005 |
664 |
FUNGAL INFECTION |
13 |
0.0005 |
665 |
PHARYNGITIS |
5 |
0.0005 |
666 |
DISCOMFORT |
21 |
0.0005 |
667 |
THERAPY INTERRUPTED |
14 |
0.0005 |
668 |
FLUID RETENTION |
20 |
0.0005 |
669 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0005 |
670 |
HAEMATOCHEZIA |
20 |
0.0005 |
671 |
ASPHYXIA |
3 |
0.0005 |
672 |
RENAL PAIN |
4 |
0.0005 |
673 |
DRUG INTOLERANCE |
34 |
0.0005 |
674 |
OSTEOPENIA |
6 |
0.0005 |
675 |
ROTATOR CUFF SYNDROME |
5 |
0.0005 |
676 |
NEOPLASM MALIGNANT |
24 |
0.0005 |
677 |
PALPITATIONS |
44 |
0.0005 |
678 |
INTENTIONAL DOSE OMISSION |
5 |
0.0005 |
679 |
ERUCTATION |
6 |
0.0005 |
680 |
CONTUSION |
35 |
0.0005 |
681 |
MENTAL IMPAIRMENT |
9 |
0.0005 |
682 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
9 |
0.0005 |
683 |
ABDOMINAL PAIN |
84 |
0.0005 |
684 |
SENSORY LOSS |
3 |
0.0005 |
685 |
CEREBROVASCULAR ACCIDENT |
65 |
0.0005 |
686 |
LIMB DISCOMFORT |
11 |
0.0004 |
687 |
HEPATITIS C |
5 |
0.0004 |
688 |
ADVERSE EVENT |
33 |
0.0004 |
689 |
ADVERSE DRUG REACTION |
28 |
0.0004 |
690 |
DECUBITUS ULCER |
3 |
0.0004 |
691 |
FATIGUE |
268 |
0.0004 |
692 |
DIZZINESS |
176 |
0.0004 |
693 |
ASTHENIA |
130 |
0.0004 |
694 |
PARAESTHESIA |
57 |
0.0004 |
695 |
BACTERIAL INFECTION |
6 |
0.0004 |
696 |
PULMONARY EMBOLISM |
35 |
0.0004 |
697 |
MUSCLE ATROPHY |
4 |
0.0004 |
698 |
LOWER LIMB FRACTURE |
6 |
0.0004 |
699 |
COAGULOPATHY |
6 |
0.0004 |
700 |
FLATULENCE |
19 |
0.0004 |
701 |
HEPATIC CIRRHOSIS |
6 |
0.0004 |
702 |
ANAEMIA |
66 |
0.0004 |
703 |
BRAIN NEOPLASM |
3 |
0.0004 |
704 |
PRURITUS |
112 |
0.0004 |
705 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
0.0004 |
706 |
DEPRESSED MOOD |
17 |
0.0004 |
707 |
FEAR |
10 |
0.0004 |
708 |
LIP SWELLING |
11 |
0.0004 |
709 |
SKIN CANCER |
7 |
0.0004 |
710 |
CYSTITIS |
11 |
0.0004 |
711 |
EYE DISCHARGE |
3 |
0.0004 |
712 |
HYPERHIDROSIS |
44 |
0.0004 |
713 |
FLUID OVERLOAD |
6 |
0.0004 |
714 |
NERVE COMPRESSION |
3 |
0.0004 |
715 |
BREAST CANCER FEMALE |
10 |
0.0004 |
716 |
CONFUSIONAL STATE |
54 |
0.0004 |
717 |
CHRONIC KIDNEY DISEASE |
28 |
0.0004 |
718 |
ARTHRALGIA |
127 |
0.0004 |
719 |
HYPERSOMNIA |
9 |
0.0004 |
720 |
LIGAMENT SPRAIN |
3 |
0.0004 |
721 |
LYMPHOMA |
5 |
0.0004 |
722 |
THERAPEUTIC RESPONSE DECREASED |
18 |
0.0004 |
723 |
BONE DENSITY DECREASED |
11 |
0.0004 |
724 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0004 |
725 |
UNEVALUABLE EVENT |
25 |
0.0004 |
726 |
RENAL IMPAIRMENT |
25 |
0.0004 |
727 |
TENDON RUPTURE |
4 |
0.0004 |
728 |
HEADACHE |
192 |
0.0004 |
729 |
INCORRECT PRODUCT STORAGE |
5 |
0.0004 |
730 |
FEEDING DISORDER |
5 |
0.0004 |
731 |
EYE PAIN |
15 |
0.0004 |
732 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0004 |
733 |
GAIT INABILITY |
8 |
0.0004 |
734 |
ARTERIOSCLEROSIS |
3 |
0.0004 |
735 |
TOOTH DISORDER |
7 |
0.0004 |
736 |
INTRAOCULAR PRESSURE INCREASED |
4 |
0.0004 |
737 |
MOTOR DYSFUNCTION |
3 |
0.0004 |
738 |
BONE DISORDER |
6 |
0.0004 |
739 |
INFECTION |
40 |
0.0004 |
740 |
EYE PRURITUS |
8 |
0.0004 |
741 |
COLITIS |
10 |
0.0004 |
742 |
HYPOTENSION |
59 |
0.0004 |
743 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0004 |
744 |
SEIZURE |
30 |
0.0004 |
745 |
NEUTROPHIL COUNT INCREASED |
3 |
0.0004 |
746 |
EAR INFECTION |
7 |
0.0004 |
747 |
OCULAR HYPERAEMIA |
12 |
0.0004 |
748 |
PNEUMONIA ASPIRATION |
7 |
0.0004 |
749 |
BLINDNESS UNILATERAL |
4 |
0.0004 |
750 |
ABDOMINAL DISCOMFORT |
46 |
0.0004 |
751 |
HEPATOMEGALY |
3 |
0.0004 |
752 |
SCAR |
5 |
0.0004 |
753 |
BLOOD PRESSURE FLUCTUATION |
7 |
0.0003 |
754 |
VOMITING |
128 |
0.0003 |
755 |
MASS |
4 |
0.0003 |
756 |
RENAL DISORDER |
13 |
0.0003 |
757 |
DIPLOPIA |
7 |
0.0003 |
758 |
DEVICE OCCLUSION |
3 |
0.0003 |
759 |
EATING DISORDER |
6 |
0.0003 |
760 |
ARTHROPOD BITE |
2 |
0.0003 |
761 |
TUBULOINTERSTITIAL NEPHRITIS |
5 |
0.0003 |
762 |
PARALYSIS |
4 |
0.0003 |
763 |
PRODUCT PHYSICAL ISSUE |
5 |
0.0003 |
764 |
SCAB |
3 |
0.0003 |
765 |
INSOMNIA |
74 |
0.0003 |
766 |
BRADYCARDIA |
15 |
0.0003 |
767 |
NEUTROPHIL COUNT DECREASED |
10 |
0.0003 |
768 |
RENAL FAILURE |
39 |
0.0003 |
769 |
DRUG EFFECT DECREASED |
18 |
0.0003 |
770 |
LOSS OF CONSCIOUSNESS |
35 |
0.0003 |
771 |
DRUG INEFFECTIVE |
344 |
0.0003 |
772 |
DYSSTASIA |
8 |
0.0003 |
773 |
BLOOD SODIUM DECREASED |
5 |
0.0003 |
774 |
MOOD SWINGS |
9 |
0.0003 |
775 |
HAEMORRHAGE |
27 |
0.0003 |
776 |
SPINAL PAIN |
3 |
0.0003 |
777 |
HOSPITALISATION |
35 |
0.0003 |
778 |
RASH |
108 |
0.0003 |
779 |
HYPONATRAEMIA |
15 |
0.0003 |
780 |
DIARRHOEA |
161 |
0.0003 |
781 |
COGNITIVE DISORDER |
12 |
0.0003 |
782 |
OSTEOMYELITIS |
5 |
0.0003 |
783 |
BLOOD GLUCOSE FLUCTUATION |
3 |
0.0003 |
784 |
GASTRIC DISORDER |
11 |
0.0003 |
785 |
PRODUCT PRESCRIBING ERROR |
5 |
0.0003 |
786 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
787 |
BIPOLAR DISORDER |
3 |
0.0003 |
788 |
VERTIGO |
16 |
0.0003 |
789 |
RESPIRATORY FAILURE |
19 |
0.0003 |
790 |
ATRIOVENTRICULAR BLOCK |
2 |
0.0003 |
791 |
HAEMATOMA |
7 |
0.0003 |
792 |
POST PROCEDURAL COMPLICATION |
5 |
0.0003 |
793 |
SKIN DISORDER |
8 |
0.0003 |
794 |
NECK PAIN |
14 |
0.0003 |
795 |
DRUG PRESCRIBING ERROR |
6 |
0.0003 |
796 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
6 |
0.0003 |
797 |
PAIN |
157 |
0.0003 |
798 |
HYPOKALAEMIA |
11 |
0.0003 |
799 |
EXPIRED PRODUCT ADMINISTERED |
8 |
0.0003 |
800 |
IMMUNODEFICIENCY |
3 |
0.0003 |
801 |
INJECTION SITE PAIN |
66 |
0.0003 |
802 |
APNOEA |
2 |
0.0003 |
803 |
TUBERCULOSIS |
3 |
0.0003 |
804 |
METASTASES TO LIVER |
4 |
0.0003 |
805 |
LETHARGY |
14 |
0.0003 |
806 |
ARTHROPATHY |
13 |
0.0003 |
807 |
URINARY INCONTINENCE |
7 |
0.0003 |
808 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0003 |
809 |
HYPOAESTHESIA |
35 |
0.0003 |
810 |
ACUTE KIDNEY INJURY |
33 |
0.0003 |
811 |
BLOOD POTASSIUM DECREASED |
7 |
0.0003 |
812 |
RENAL INJURY |
8 |
0.0003 |
813 |
ANGIOEDEMA |
10 |
0.0003 |
814 |
MENTAL DISORDER |
10 |
0.0003 |
815 |
COMPLICATION ASSOCIATED WITH DEVICE |
3 |
0.0003 |
816 |
LYMPHADENOPATHY |
8 |
0.0003 |
817 |
FAECES DISCOLOURED |
5 |
0.0003 |
818 |
PERICARDIAL EFFUSION |
5 |
0.0003 |
819 |
EPISTAXIS |
17 |
0.0003 |
820 |
PSYCHOMOTOR HYPERACTIVITY |
4 |
0.0003 |
821 |
COLD SWEAT |
4 |
0.0003 |
822 |
HEPATIC STEATOSIS |
4 |
0.0003 |
823 |
ANAPHYLACTIC REACTION |
11 |
0.0003 |
824 |
GASTROINTESTINAL DISORDER |
16 |
0.0003 |
825 |
PERIPHERAL COLDNESS |
3 |
0.0003 |
826 |
SKIN DISCOLOURATION |
10 |
0.0003 |
827 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
8 |
0.0003 |
828 |
NEURALGIA |
5 |
0.0003 |
829 |
ABDOMINAL PAIN UPPER |
43 |
0.0003 |
830 |
CHROMATURIA |
5 |
0.0003 |
831 |
PHARYNGEAL OEDEMA |
4 |
0.0003 |
832 |
IRRITABLE BOWEL SYNDROME |
4 |
0.0003 |
833 |
FEMUR FRACTURE |
7 |
0.0003 |
834 |
JOINT SWELLING |
24 |
0.0003 |
835 |
LACTIC ACIDOSIS |
6 |
0.0003 |
836 |
MYELODYSPLASTIC SYNDROME |
3 |
0.0003 |
837 |
METASTASES TO BONE |
3 |
0.0003 |
838 |
CONSTIPATION |
41 |
0.0003 |
839 |
RHEUMATOID ARTHRITIS |
22 |
0.0003 |
840 |
HAEMORRHOIDS |
4 |
0.0002 |
841 |
COLON CANCER |
3 |
0.0002 |
842 |
CEREBRAL INFARCTION |
5 |
0.0002 |
843 |
DEAFNESS |
5 |
0.0002 |
844 |
PULMONARY ARTERIAL HYPERTENSION |
3 |
0.0002 |
845 |
HEART RATE DECREASED |
7 |
0.0002 |
846 |
ANGINA PECTORIS |
6 |
0.0002 |
847 |
ANGER |
7 |
0.0002 |
848 |
EJECTION FRACTION DECREASED |
3 |
0.0002 |
849 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
24 |
0.0002 |
850 |
ROAD TRAFFIC ACCIDENT |
8 |
0.0002 |
851 |
PSORIASIS |
25 |
0.0002 |
852 |
ANKYLOSING SPONDYLITIS |
2 |
0.0002 |
853 |
STOMATITIS |
11 |
0.0002 |
854 |
ULCER |
3 |
0.0002 |
855 |
DRUG INTERACTION |
30 |
0.0002 |
856 |
CARDIAC ARREST |
16 |
0.0002 |
857 |
GASTRITIS |
5 |
0.0002 |
858 |
PRURITUS GENERALISED |
5 |
0.0002 |
859 |
DEVICE BREAKAGE |
5 |
0.0002 |
860 |
TENDONITIS |
3 |
0.0002 |
861 |
LOCAL SWELLING |
4 |
0.0002 |
862 |
BONE LOSS |
3 |
0.0002 |
863 |
INCREASED APPETITE |
3 |
0.0002 |
864 |
ARRHYTHMIA |
9 |
0.0002 |
865 |
PRODUCT DISPENSING ERROR |
3 |
0.0002 |
866 |
DRUG EFFECT INCOMPLETE |
8 |
0.0002 |
867 |
INTESTINAL OBSTRUCTION |
6 |
0.0002 |
868 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
4 |
0.0002 |
869 |
NAUSEA |
134 |
0.0002 |
870 |
PULMONARY FIBROSIS |
3 |
0.0002 |
871 |
DEATH |
143 |
0.0002 |
872 |
THROMBOSIS |
14 |
0.0002 |
873 |
THIRST |
3 |
0.0002 |
874 |
PAIN IN JAW |
5 |
0.0002 |
875 |
PRESYNCOPE |
4 |
0.0002 |
876 |
DISORIENTATION |
7 |
0.0002 |
877 |
DRUG RESISTANCE |
4 |
0.0002 |
878 |
ANHEDONIA |
5 |
0.0002 |
879 |
NIGHT SWEATS |
5 |
0.0002 |
880 |
URTICARIA |
26 |
0.0002 |
881 |
CEREBRAL HAEMORRHAGE |
6 |
0.0002 |
882 |
ABASIA |
5 |
0.0002 |
883 |
DEHYDRATION |
22 |
0.0002 |
884 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
885 |
FULL BLOOD COUNT DECREASED |
3 |
0.0002 |
886 |
DRUG ADMINISTRATION ERROR |
6 |
0.0002 |
887 |
FRACTURE |
3 |
0.0002 |
888 |
AGITATION |
12 |
0.0002 |
889 |
SWELLING |
14 |
0.0002 |
890 |
PLATELET COUNT DECREASED |
16 |
0.0002 |
891 |
SKIN ULCER |
4 |
0.0002 |
892 |
PRODUCT SUBSTITUTION ISSUE |
9 |
0.0002 |
893 |
WHITE BLOOD CELL COUNT INCREASED |
6 |
0.0002 |
894 |
SOMNOLENCE |
30 |
0.0002 |
895 |
POOR QUALITY SLEEP |
3 |
0.0002 |
896 |
ACCIDENTAL OVERDOSE |
5 |
0.0002 |
897 |
MOOD ALTERED |
4 |
0.0002 |
898 |
GLOSSODYNIA |
3 |
0.0002 |
899 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0002 |
900 |
FEELING HOT |
9 |
0.0002 |
901 |
PALLOR |
4 |
0.0002 |
902 |
BLOOD GLUCOSE DECREASED |
7 |
0.0002 |
903 |
NEUROPATHY PERIPHERAL |
12 |
0.0002 |
904 |
RECTAL HAEMORRHAGE |
6 |
0.0002 |
905 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
906 |
INTERVERTEBRAL DISC PROTRUSION |
3 |
0.0002 |
907 |
INTERSTITIAL LUNG DISEASE |
6 |
0.0002 |
908 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0002 |
909 |
APHASIA |
4 |
0.0002 |
910 |
THERAPEUTIC RESPONSE UNEXPECTED |
6 |
0.0002 |
911 |
EYE IRRITATION |
6 |
0.0002 |
912 |
PANCREATIC CARCINOMA |
4 |
0.0002 |
913 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
11 |
0.0002 |
914 |
RASH GENERALISED |
4 |
0.0002 |
915 |
PRODUCT ADHESION ISSUE |
4 |
0.0002 |
916 |
BONE PAIN |
7 |
0.0001 |
917 |
NERVOUS SYSTEM DISORDER |
4 |
0.0001 |
918 |
SUICIDAL IDEATION |
11 |
0.0001 |
919 |
RASH PRURITIC |
6 |
0.0001 |
920 |
C-REACTIVE PROTEIN INCREASED |
4 |
0.0001 |
921 |
HYPERKALAEMIA |
4 |
0.0001 |
922 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
923 |
MUSCULOSKELETAL STIFFNESS |
10 |
0.0001 |
924 |
ABNORMAL BEHAVIOUR |
5 |
0.0001 |
925 |
AGGRESSION |
6 |
0.0001 |
926 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
927 |
DEVICE LEAKAGE |
3 |
0.0001 |
928 |
COVID-19 |
16 |
0.0001 |
929 |
BLOOD GLUCOSE INCREASED |
22 |
0.0001 |
930 |
EYE SWELLING |
4 |
0.0001 |
931 |
PRODUCT STORAGE ERROR |
6 |
0.0001 |
932 |
FLUSHING |
12 |
0.0001 |
933 |
COLITIS ULCERATIVE |
4 |
0.0001 |
934 |
SWELLING FACE |
7 |
0.0001 |
935 |
RED BLOOD CELL COUNT DECREASED |
3 |
0.0001 |
936 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
937 |
JAUNDICE |
3 |
0.0001 |
938 |
TREATMENT NONCOMPLIANCE |
5 |
0.0001 |
939 |
CRYING |
4 |
0.0001 |
940 |
OVERDOSE |
22 |
0.0001 |
941 |
BLADDER CANCER |
7 |
0.0001 |
942 |
HOT FLUSH |
7 |
0.0001 |
943 |
SEPSIS |
11 |
0.0001 |
944 |
RESPIRATORY ARREST |
3 |
0.0001 |
945 |
DYSKINESIA |
4 |
0.0001 |
946 |
IMPAIRED HEALING |
3 |
0.0001 |
947 |
WHITE BLOOD CELL COUNT DECREASED |
10 |
0.0001 |
948 |
PANCREATITIS |
5 |
0.0001 |
949 |
ERYTHEMA |
19 |
0.0001 |
950 |
TARDIVE DYSKINESIA |
3 |
0.0001 |
951 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
952 |
INCORRECT DRUG ADMINISTRATION DURATION |
3 |
0.0001 |
953 |
MALIGNANT NEOPLASM PROGRESSION |
8 |
0.0001 |
954 |
HALLUCINATION |
6 |
0.0001 |
955 |
PROSTATE CANCER |
8 |
0.0001 |
956 |
DEEP VEIN THROMBOSIS |
6 |
0.0001 |
957 |
BREAST CANCER |
9 |
0.0001 |
958 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
959 |
NIGHTMARE |
3 |
0.0001 |
960 |
SKIN BURNING SENSATION |
6 |
0.0001 |
961 |
FEBRILE NEUTROPENIA |
5 |
0.0001 |
962 |
HYPERGLYCAEMIA |
3 |
0.0001 |
963 |
EMOTIONAL DISTRESS |
11 |
0.0001 |
964 |
SURGERY |
4 |
0.0001 |
965 |
WITHDRAWAL SYNDROME |
3 |
0.0001 |
966 |
BLOOD CREATININE INCREASED |
5 |
0.0001 |
967 |
DISEASE PROGRESSION |
8 |
0.0001 |
968 |
RASH ERYTHEMATOUS |
3 |
0.0001 |
969 |
SEPTIC SHOCK |
3 |
0.0001 |
970 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
971 |
INFUSION RELATED REACTION |
4 |
0.0001 |
972 |
DRY SKIN |
8 |
0.0001 |
973 |
ASCITES |
2 |
0.0001 |
974 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
975 |
TINNITUS |
3 |
0.0001 |
976 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
977 |
COMA |
3 |
0.0001 |
978 |
INJECTION SITE PRURITUS |
4 |
0.0001 |
979 |
ALOPECIA |
12 |
0.0001 |
980 |
TREATMENT FAILURE |
4 |
0.0001 |
981 |
RENAL CANCER |
3 |
0.0001 |
982 |
INJECTION SITE SWELLING |
3 |
0.0001 |
983 |
INJECTION SITE HAEMORRHAGE |
3 |
0.0001 |
984 |
SKIN EXFOLIATION |
3 |
0.0000 |
985 |
INJURY |
3 |
0.0000 |
986 |
DRUG WITHDRAWAL SYNDROME |
4 |
0.0000 |
987 |
ACNE |
3 |
0.0000 |
988 |
THROMBOCYTOPENIA |
4 |
0.0000 |
989 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
990 |
NO ADVERSE EVENT |
4 |
0.0000 |